demonstrated that miR-1305 targeted ubiquitin-conjugating enzyme E2T (UBE2T) to suppress the Akt signaling pathway and then prevented the self-renewal and tumorigenicity of cancer stem cells in HCC (30). This evidence concerns the gene UBE2T and hepatocellular carcinoma.